Analystreport

TRACON Pharmaceuticals Inc (NASDAQ: TCON) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $4.00 price target on the stock.

TRACON Pharmaceuticals, Inc.  (TCON) 
Last tracon pharmaceuticals, inc. earnings: 2/27 04:03 pm Check Earnings Report
US:NASDAQ Investor Relations: traconpharma.com